<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02354664</url>
  </required_header>
  <id_info>
    <org_study_id>IRB201400763</org_study_id>
    <nct_id>NCT02354664</nct_id>
  </id_info>
  <brief_title>Dynamic Respiratory Muscle Function in Late-Onset Pompe Disease</brief_title>
  <acronym>DRMF</acronym>
  <official_title>Dynamic Respiratory Muscle Function in Late-Onset Pompe Disease</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Florida</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>BioMarin Pharmaceutical</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Florida</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study intends to evaluate dynamic respiratory motor performance as a valuable measure of
      pulmonary function in adults with late-onset Pompe disease. The investigators will adopt a
      strategy that includes comprehensive evaluations of respiratory volume, flow, and timing
      parameters during resting and loaded breathing. These evaluations will then be associated to
      the standard clinical measure of maximal inspiratory pressure, the static inspiratory muscle
      function, as well as magnetic resonance imaging of thoracic expansion and diaphragmatic
      descent at rest and with exertion. Outcomes in participants with late-onset Pompe disease
      will be contrasted to the function of age- and gender-matched control subjects. This approach
      will enable the investigators to evaluate the relationship between dynamic diaphragmatic
      function and respiratory motor function.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The following tests will be completed over a two-day period: Respiratory pressure tests,
      breathing test, magnetic resonance imaging and magnetic resonance spectroscopy (MRI and MRS).
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">April 2015</start_date>
  <completion_date type="Anticipated">May 2018</completion_date>
  <primary_completion_date type="Anticipated">May 2018</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Inspiratory load compensation</measure>
    <time_frame>Day 1</time_frame>
    <description>Peak inspiratory flow, inspiratory volume, and duty cycle of loaded breaths will be measured</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Respiratory muscle endurance task</measure>
    <time_frame>Day 2</time_frame>
    <description>Time and load associated with endurance task failure will be measured.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Inspiratory load Compensation</measure>
    <time_frame>Day 2</time_frame>
    <description>Peak inspiratory flow, inspiratory volume, and duty cycle of loaded breaths will be measured</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Thoracic MRI</measure>
    <time_frame>Day 1</time_frame>
    <description>Chest wall and diaphragmatic motions will be measured in three planes with dynamic magnetic resonance imaging (MRI). The change in diaphragm excursion between full inspiration and full expiration will be measured in the frontal plane, and change in the area of the right and left sides of the chest cavity will be measured in the sagittal plane. Diaphragm and chest excursion will be recorded dynamically during 30-second periods of resting breathing and deep breathing.</description>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">19</enrollment>
  <condition>Pompe Disease</condition>
  <arm_group>
    <arm_group_label>Pompe subjects</arm_group_label>
    <description>These subjects will receive a thoracic MRI, spirometry, inspiratory load compensation, maximal inspiratory pressure, resting breathing pattern, respiratory muscle endurance test.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control subjects</arm_group_label>
    <description>These subjects will receive a thoracic MRI, spirometry, inspiratory load compensation, maximal inspiratory pressure, resting breathing pattern, respiratory muscle endurance test.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Thoracic MRI</intervention_name>
    <description>Imaging of the diaphragm will be completed during resting breathing, and then during a maximal voluntary ventilation maneuver.</description>
    <arm_group_label>Pompe subjects</arm_group_label>
    <arm_group_label>Control subjects</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Spirometry</intervention_name>
    <description>Upright forced vital capacity (FVC)</description>
    <arm_group_label>Pompe subjects</arm_group_label>
    <arm_group_label>Control subjects</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Inspiratory Load Compensation</intervention_name>
    <description>A spring-loaded pressure device will resist inspiration. The patient must generate the threshold inspiratory pressure to receive airflow. The changes in breathing timing, flow and volume will be recorded.</description>
    <arm_group_label>Pompe subjects</arm_group_label>
    <arm_group_label>Control subjects</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Maximal Inspiratory Pressure</intervention_name>
    <description>Measure the maximal airflow on inhalation</description>
    <arm_group_label>Pompe subjects</arm_group_label>
    <arm_group_label>Control subjects</arm_group_label>
    <other_name>MIP</other_name>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Resting Breathing Pattern</intervention_name>
    <description>The breathing pattern will be assessed when the subject is seated and in a relaxed state.</description>
    <arm_group_label>Pompe subjects</arm_group_label>
    <arm_group_label>Control subjects</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Respiratory Muscle Endurance Test</intervention_name>
    <description>Evaluates the time limit that a participant can maintain ventilation while breathing with a submaximal inspiratory threshold load.</description>
    <arm_group_label>Pompe subjects</arm_group_label>
    <arm_group_label>Control subjects</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Subjects with late-onset Pompe disease, age 20-60 years, and age and gender-matched
        unaffected control subjects
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Confirmed diagnosis of Pompe disease OR

          -  Be an age and gender-matched unaffected control subject

        Exclusion Criteria:

          -  Pre-existing obstructive lung disease or asthma

          -  Forced vital capacity (FVC) &lt;30% or &gt;80% of age/gender predicted values

          -  Inability to travel to the study site

          -  Requirement for positive pressure ventilator support when awake and upright

          -  Participation in longitudinal studies that may independently alter lung function

          -  Presence of any other chronic medical condition that, in the opinion of the
             investigator, would make the subject unsuitable for the study
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Barbara K. Smith, PT, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Florida</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Barbara K. Smith, PT, PhD</last_name>
    <phone>352-294-5315</phone>
    <email>bksmith@phhp.ufl.edu</email>
  </overall_contact>
  <location>
    <facility>
      <name>University of Florida</name>
      <address>
        <city>Gainesville</city>
        <state>Florida</state>
        <zip>32606</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Lee Kugelmann</last_name>
      <phone>352-273-6855</phone>
      <email>ekugelm@ufl.edu</email>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>January 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 21, 2015</study_first_submitted>
  <study_first_submitted_qc>January 29, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 3, 2015</study_first_posted>
  <last_update_submitted>January 4, 2018</last_update_submitted>
  <last_update_submitted_qc>January 4, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">January 8, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>respiratory test</keyword>
  <keyword>respiratory muscle endurance</keyword>
  <keyword>spirometry</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Glycogen Storage Disease Type II</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

